key: cord-0685514-lfl82yjr
authors: Dudouet, Pierre; Cammilleri, Serge; Guedj, Eric; Jacquier, Alexis; Raoult, Didier; Eldin, Carole
title: Aortic [18F] FDG-PET/CT hypermetabolism in patients with long COVID: a retrospective study
date: 2021-09-27
journal: Clin Microbiol Infect
DOI: 10.1016/j.cmi.2021.09.020
sha: 3617bd97dded0129705bdd250b2f211e501ab0a6
doc_id: 685514
cord_uid: lfl82yjr

nan

symptoms more than 4 weeks after COVID-19 [1] . Recently, Sollini et al. described an 28 increased 18 F-FDG vascular uptake in 6 patients with long COVID [2] . We retrospectively 29 searched for vascular hypermetabolism among patients consulting for long COVID, who had 30 a whole body 18F FDG PET/CT as part of routine exploration. This retrospective study was 31 approved by the hospital board (AP-HM) on the following reference: PADSVJWVK7, and 32 data extracted respecting the French GPDR (General Data Protection Regulation Aortic hypermetabolism was visually detected in 10 patients, with an aortic mean 45 SUVmax measured at 3.36 (SD = 0.63) ( Figure 1 ). Thoracic aorta segment was involved in all 46 patients. Abdominal aortic hypermetabolism was additionally found in 3 patients. Five patients were controlled with a second 18 F-FDG PET/CT scan (mean delay 152 days). Four 48 out of 5 showed a persistent aortic hypermetabolism. The mean of aortic SUVmax in the 10 49 aortic hypermetabolism patients was higher than in the 37 non-aortic hypermetabolism 50 patients (3.36, SD 0.63 and 2.51, SD 0.18, respectively, p=0,002). Three out of 10 patients 51 had a thoracic CT angiography to measure aortic diameters and volumes. No significant 52 parietal thickening on ascending or descending thoracic aorta nor on abdominal aorta was 53 found on CT angiography. 54

The group of 10 patients with aortic hypermetabolism was composed of six women 55 (6/10), with mean age at 55 years (44-71), and mean BMI at 25 (23-29). Five patients were 56 smokers (one active and four former smokers). One patient had high blood pressure and one 57 patient had past cardiovascular events (arrythmia and stroke). Three patients had chest pain 58 during acute COVID-19 (3/9), one patient had dyspnoea (1/9), and one had a severe lesion on 59 chest CT-scan (1/7). The clinical features of long COVID were dyspnoea (7/10), chest pain 60 (6/10) and cognitive complains (6/10). When compared with the 37 controls with a negative 61 aortic PET, we found significant differences regarding tobacco smoking at baseline (5/10; 62 50% vs 31/37; 83%, p=0.04), dyspnea during the acute stage (1/9; 11% vs 19/36; 52%, 63 p=0.03), persistent ageusia (0/10 vs 14/37; 38%, p=0.02) and persistent chest pain (6/10; 60% 64 vs 7/37; 19%, p=0.017). No other significant differences were found between the two groups. 65 Biologically, all patients had a normal C-Reactive protein rate, and we performed Treponema 66 pallidum serology for 6 patients, that were all negative. 67

To resume, we retrospectively found aortic hypermetabolism in 10 out of 47 patients 68 with long COVID who had a 18 F-FDG PET/CT scan, with more frequent chest pain in this 69 group (6/10; 60% vs 7/37; 19%, p=0.017). The high proportion of aortic hypermetabolism in 70 our cohort (21%) makes us think that this phenomenon is not incidental. To have an idea of 71 the prevalence of incidental finding of thoracic aortic hypermetabolism, we compared 72 thoracic aortic uptakes between our long COVID patients, and a non-COVID-19 control patients with aortic hypermetabolism and non-COVID-19 control group (3.36, SD 0.63 and 78 2.15 (SD 0.59), respectively; p< 0.0001). 79

This study is retrospective and, consequently, suffers from several biases. No previous 80 18 F-FDG PET/CT scan was available for the patients, and we could not exclude the possibility 81 that some had a pre-existing aortic hypermetabolism. Nonetheless, they had no more 82 cardiovascular risks factors than the controls, including tobacco and age, suggesting that 83 aortic hypermetabolism was probably not due to previous unknown atherosclerotic lesions. 84 However, we found significant differences between small groups of patients, and the 85 relevance of our results needs to be confirmed by further studies on larger samples. No external funding was received for this study 119

The authors declare that they have no conflicts of interest 121 122

Use of all data was secured by password protection of all folders, and was approved by the 124 legal General Data Protection Regulation team from the "Assistance Publique des Hôpitaux 125 

Symptômes prolongés suite à une Covid-19 de l'adulte -Diagnostic et prise en charge

Vasculitis 136 changes in COVID-19 survivors with persistent symptoms: an [18F]FDG-PET/CT study

Florid aortitis following SARS-CoV-2 infection

EP14 COVID-19 associated aortitis

SARS-CoV-2 (COVID-19) pneumonia: 144 Incidental finding on 18F-FDG PET/CT study for vasculitis diagnosis

Long 147 COVID hallmarks on [18F]FDG-PET/CT: a case-control study

Vascular Biology, and the ESC Council of Basic Cardiovascular Science